Abukiwan, A., Nwaeburu, C. C., Bauer, N., Zhao, Z., Liu, L., Gladkich, J., . . . Herr, I. (2019). Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer. International journal of oncology, 54(1), . https://doi.org/10.3892/ijo.2018.4616
Chicago Style (17th ed.) CitationAbukiwan, Alia, et al. "Dexamethasone-induced Inhibition of MiR-132 via Methylation Promotes TGF-β-driven Progression of Pancreatic Cancer." International Journal of Oncology 54, no. 1 (2019). https://doi.org/10.3892/ijo.2018.4616.
MLA (9th ed.) CitationAbukiwan, Alia, et al. "Dexamethasone-induced Inhibition of MiR-132 via Methylation Promotes TGF-β-driven Progression of Pancreatic Cancer." International Journal of Oncology, vol. 54, no. 1, 2019, https://doi.org/10.3892/ijo.2018.4616.